Liver X receptors: Emerging therapeutic targets for Alzheimer's disease
Authors:
- Nirmal SinghNSNirmal Singh
- 1 June 2013
- journal article
- review article
- Published by Elsevier in Pharmacological Research
- Vol. 72, 45-51
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Liver X receptor biology and pharmacology: new pathways, challenges and opportunitiesTrends in Pharmacological Sciences, 2012
- ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse ModelsScience, 2012
- ATP-binding Cassette Transporter A1 Mediates the Beneficial Effects of the Liver X Receptor Agonist GW3965 on Object Recognition Memory and Amyloid Burden in Amyloid Precursor Protein/Presenilin 1 Mice*Journal of Biological Chemistry, 2010
- Tissue-Specific Liver X Receptor Activation Promotes Macrophage Reverse Cholesterol Transport In VivoArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Systemic inflammation and disease progression in Alzheimer diseaseNeurology, 2009
- ApoE Promotes the Proteolytic Degradation of AβNeuron, 2008
- Degradation of fibrillar forms of Alzheimer's amyloid β-peptide by macrophagesNeurobiology of Aging, 2008
- Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptorsProceedings of the National Academy of Sciences, 2007
- Transport Pathways for Clearance of Human Alzheimer's Amyloid β-Peptide and Apolipoproteins E and J in the Mouse Central Nervous SystemJournal of Cerebral Blood Flow & Metabolism, 2007
- The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer diseaseNature Genetics, 2007